Vertex Pharmaceuticals Incorporated financial statements, including revenue, expenses, profit, and loss
The total revenue of VRTX for the last quarter is 2.52 B USD, and it's 1.60% higher compared to the previous quarter. The net income of Q4 23 is 968.80 M USD.